Trial intelligence / Profile preview

The Clinical Carbetocin Myocardium Trial

NCT02528136Phase 4Completed

Sponsor
Oslo University Hospital
Start
Sep 2015
Primary completion
Jan 2019
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of carbetocin in postpartum hemorrhage (PPH), sponsored by Oslo University Hospital. Started Sep 2015; status: completed.

02

Drugs

carbetocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02528136.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02528136.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call